Guangzhou Darui Biotechnology Company Profile - aVenture Research
Guangzhou Darui Biotechnology
Guangzhou Darui Biotechnology is a biomedical high-tech in vitro diagnostics company integrating in-vitro diagnostic products, medical testing, and innovation incubation.
Guangzhou Darui Biotechnology is a multi-method in-vitro diagnostics company. It is a high-tech enterprise focused on molecular diagnostic techniques. Upon completing its joint-stock reform, the company changed its name from 广州市达瑞抗体工程技术有限公司, its earlier antibody-engineering name.
The company researches, develops, produces, and services in-vitro diagnostic products, including time-resolved fluoroimmunoassay, chemiluminescence immunoassay, next-generation sequencing, ELISA, tandem and time-of-flight mass spectrometry, and CD-DST drug-sensitivity testing, as diagnostic kits and equipment. Its distribution network covers all of mainland China. The DR MassARRAY system adapts Agena's MassARRAY technology with local research and production and is designed for hospitals and clinical testing centers.
Darui's multi-platform scientific research service covers genome, transcriptome, exome, epigenome, and metagenome sequencing across human, animal, plant, and microbial samples.
DR TQ Mass, Darui’s precision-medicine-centered tandem mass spectrometry platform, develops and applies testing products in birth-health and tumor fields.